Oprah Winfrey is opening up about how using weight-loss drugs (like Ozempic, Wegovy and Mounjaro) has impacted the way she ...

A-lister Oprah Winfrey recently revealed that her opinion on "thin people" has dramatically changed since starting her weight ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Many of them have only been approved for sale in the last few years. The most widely known of GLP-1 drugs, semaglutide is sold under well-known brand names such as Ozempic and Wegovy. According to the ...

Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food and drink makers to cash in. Consumers taking GLP-1 drugs to lose weight ...

Retatrutide — an experimental drug nicknamed “triple G” — could ... the active ingredient in Ozempic and Wegovy. Obese adults who took the weekly injection retatrutide lost up to 22% ...

American pharmaceutical giant Eli Lilly is the maker of weight-loss drug Mounjaro. Bloomberg Eli Lilly is expected to lodge a submission to have Mounjaro, which competes with Ozempic as one of ...